Answer
In patients receiving haemodialysis, difelikefalin acetate (Kapruvia) has a mean elimination half-life ranging from 23 to 31 hours, approximately tenfold longer than in people with normal renal function.
Sources for this answer
- Kapruvia 50 micrograms/mL solution for injectionVifor Fresenius Medical Care Renal Pharma UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 5Document updated
Sources checked